MedMira Inc.
MMIRF · OTC
4/30/2025 | 1/31/2025 | 10/31/2024 | 7/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | 1.71 | -0.91 | -0.23 |
| FCF Yield | -4.59% | -0.83% | -1.78% | -2.60% |
| EV / EBITDA | -46.46 | -109.19 | -65.79 | -89.03 |
| Quality | ||||
| ROIC | 6.43% | 9.92% | 10.80% | 10.15% |
| Gross Margin | 72.76% | 66.15% | 85.51% | 58.04% |
| Cash Conversion Ratio | 0.94 | 0.59 | 0.77 | 0.65 |
| Growth | ||||
| Revenue 3-Year CAGR | -21.51% | -28.08% | -25.75% | -24.33% |
| Free Cash Flow Growth | -28.26% | 28.05% | 33.72% | -58.39% |
| Safety | ||||
| Net Debt / EBITDA | -15.62 | -10.51 | -8.67 | -10.18 |
| Interest Coverage | -2.88 | -4.47 | -4.37 | -2.86 |
| Efficiency | ||||
| Inventory Turnover | 0.07 | 0.11 | 0.05 | 0.15 |
| Cash Conversion Cycle | -11,738.27 | -8,653.87 | -23,581.00 | -6,587.35 |